3 Stocks Improving Performance Of The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 34 points (0.2%) at 16,956 as of Friday, June 20, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,547 issues advancing vs. 1,406 declining with 177 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is up 0.1%. Top gainers within the industry include Mettler-Toledo International ( MTD), up 2.2%, HCA Holdings ( HCA), up 1.7%, Smith & Nephew ( SNN), up 0.9%, Stryker Corporation ( SYK), up 0.8% and Agilent Technologies ( A), up 0.7%. On the negative front, top decliners within the industry include Opko Health ( OPK), down 2.0%, Medtronic ( MDT), down 1.0%, Grifols ( GRFS), down 0.9% and Covidien ( COV), down 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Catamaran ( CTRX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Catamaran is up $0.59 (1.4%) to $44.10 on light volume. Thus far, 780,984 shares of Catamaran exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $43.39-$44.29 after having opened the day at $43.64 as compared to the previous trading day's close of $43.51.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $9.0 billion and is part of the health care sector. Shares are down 8.3% year-to-date as of the close of trading on Thursday. Currently there are 13 analysts who rate Catamaran a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, good cash flow from operations and compelling growth in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Catamaran Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, CR Bard ( BCR) is up $1.09 (0.8%) to $140.17 on light volume. Thus far, 318,806 shares of CR Bard exchanged hands as compared to its average daily volume of 876,800 shares. The stock has ranged in price between $139.40-$140.23 after having opened the day at $139.67 as compared to the previous trading day's close of $139.08.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. CR Bard has a market cap of $10.6 billion and is part of the health care sector. Shares are up 3.8% year-to-date as of the close of trading on Thursday. Currently there are 2 analysts who rate CR Bard a buy, 1 analyst rates it a sell, and 11 rate it a hold.

TheStreet Ratings rates CR Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, expanding profit margins and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CR Bard Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, St Jude Medical ( STJ) is up $1.31 (1.9%) to $69.06 on average volume. Thus far, 1.1 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $68.09-$69.13 after having opened the day at $68.13 as compared to the previous trading day's close of $67.75.

St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. St Jude Medical has a market cap of $19.2 billion and is part of the health care sector. Shares are up 9.4% year-to-date as of the close of trading on Thursday. Currently there are 14 analysts who rate St Jude Medical a buy, 1 analyst rates it a sell, and 6 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full St Jude Medical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Trump, China Trade, Target and Las Vegas Casinos - 5 Things You Must Know

Trump, China Trade, Target and Las Vegas Casinos - 5 Things You Must Know

Stocks Move Lower on Trade Fears and 4 Other Stories You Must Know Wednesday

Stocks Move Lower on Trade Fears and 4 Other Stories You Must Know Wednesday

Target Slumps After Q1 Earnings Miss as Comparable Sales Slow, Traffic Improves

Target Slumps After Q1 Earnings Miss as Comparable Sales Slow, Traffic Improves

Pound Slides as Inflation Slows, Doubts Grow Over Bank of England Rate Hikes

Pound Slides as Inflation Slows, Doubts Grow Over Bank of England Rate Hikes